Calquence 100 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FBGR3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,790
Award facts
- Contract value 100% obligated
- $11,789.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) valued at $11,789.94 on January 29, 2026, with an ultimate completion date of February 20, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Calquence is a targeted therapy medication used in the treatment of hematologic malignancies, reflecting the DLA's ongoing need to supply specialized pharmaceutical products to military treatment facilities and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This single-award IDC serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract demonstrates AmerisourceBergen's role as a critical pharmaceutical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBGR3?
SPE2DR26FBGR3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FBGR3 worth?
The government has obligated $11,790 on SPE2DR26FBGR3.
Is contract SPE2DR26FBGR3 an order under another contract?
Yes. SPE2DR26FBGR3 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBGR3 competed?
The extent of competition for SPE2DR26FBGR3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award